sciclone pharmaceuticals inc
Former Chief Executive Officer of China Operations and Director, SciClone Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Mark Lotter was the Chief Executive Officer of China Operations at SciClone Pharmaceuticals, Inc., from April 2011 to December 14, 2012. Mr. Lotter was the Chief Executive Officer, President, and Director at NovaMed Pharmaceuticals Inc. Prior to founding NovaMed, Mr. Lotter served as Vice President, Commercial Operations of AstraZeneca China. He was largely responsible for turning AstraZeneca to the largest prescription based multinational in China. He served as ...
950 Tower LanePhone: 650-358-3456
Foster City, California 94404
Board Members Memberships*
Chief Executive Officer, President, and Director
Former Chief Executive Officer of China Operations and Director
The University of KwaZulu-Natal
University of South Africa
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Christopher Nishan Garabedian||Chief Executive Officer, President and Director|
Sarepta Therapeutics, Inc.
|Arthur P. Bedrosian J.D.||Chief Executive Officer, Director and Chairman of Strategic Planning Committee|
Lannett Company, Inc.
|Craig A. Wheeler||Chief Executive Officer, President and Executive Director|
Momenta Pharmaceuticals Inc.
|Douglas L. Drysdale||Chairman, Chief Executive Officer and President|
Pernix Therapeutics Holdings, Inc.
|Jeffrey M. Yordon||Founder, Chairman and Chief Executive Officer|
Sagent Pharmaceuticals, Inc.
|$615.2K||Compensation as of Fiscal Year 2013.|